KarenSmithMD

PubMed

• Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation.
  Rattsev, I., Blackford, A., Hertz, D., Rae, J., Taylor, C., Stearns, V., Smith, K.> ;JAMIA Open. 2024 Apr 1
• TBCRC 057: Survey about willingness to participate in cancer clinical trials during the pandemic.
  Karen Lisa Smith, Carolyn Mead-Harvey, Gina L Mazza, Eileen H Shinn, Elizabeth S Frank, Michelle E Melisko, Cyd Eaton, Yisi Liu, Jeannine M Salamone, Teri Pollastro, P...> ;Cancer Medicine. 2024 Mar 1
• Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.
  Liang, Y., Gersch, C., Lehman, J., Henry, N., Rae, J., Hertz, D., Smith, K., Stearns, V.> ;Pharmacogenetics and Genomics. 2024 Feb 8
• Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
  Karen L Smith, Fengmin Zhao, Ingrid A Mayer, Amye J Tevaarwerk, Sofia F Garcia, Carlos L Arteaga, William F Symmans, Ben H Park, Brian L Burnette, Della F Makower, Mar...> ;Cancer. 2024 Jan 18
• 1 citations
  Adjuvant treatment decisions among adults aged 65 years and older with early-stage hormone receptor positive breast cancer seen in a simple multidisciplinary clinic ve...
  Keara English, Sara R Alcorn, Hanh-Tam Tran, Karen Lisa Smith, Mary Wilkinson, Kelly Tadken Hirose, Maureen O'Donnell, Victoria Croog, Jean L Wright> ;Journal of Geriatric Oncology. 2023 May 1
• 4 citations
  Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.
  Sarah Jenkins, Wei Zhang, Seth M Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S Armstrong, Eric Burton, Dee Dee Smart, Ritu Shah, Cody J Peer, Brett Mo...> ;Clinical Cancer Research. 2023 Apr 14
• 1 citations
  Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer.
  Neha Verma, Amanda L Blackford, Elissa Thorner, Jennifer Lehman, Claire Snyder, Vered Stearns, Karen Lisa Smith> ;Breast Cancer Research and Treatment. 2022 Dec 1
• A PRO-cision medicine intervention to personalize cancer care using patient-reported outcomes: intervention development and feasibility-testing.
  Claire Snyder, Susan M Hannum, Sharon White, Amanda Montanari, Dara Ikejiani, Benjamin Smith, Amanda Blackford, Elissa Thorner, Katherine C Smith, Michael A Carducci, ...> ;Quality of Life Research. 2022 Aug 1
• 4 citations
  Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
  Elaine M Walsh, Neha Mangini, John Fetting, Deborah Armstrong, Isaac S Chan, Roisin M Connolly, Katie Fiallos, Jennifer Lehman, Raquel Nunes, Dana Petry, Jeffrey Reyno...> ;Clinical Breast Cancer. 2022 Jun 1
• 4 citations
  Late Recurrence Following Early Breast Cancer.
  Alexandra Thomas, Heather A Parsons, Karen Lisa Smith> ;Journal of Clinical Oncology. 2022 May 1
• 12 citations
  Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.
  Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook, David Lim, John Fetting, Antonio C Wolff, Daniela Jelovac, Robert S Miller, Roisin ...> ;NPJ Breast Cancer. 2022 Apr 21
• 152 citations
  NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
  William J Gradishar, Meena S Moran, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Sarah L Blair, Harold J Burstein, Chau Dang, Anthony D Elias, Sharon ...> ;Journal of the National Comprehensive Cancer Network. 2021 May 1
• 6 citations
  A bilingual dietary intervention early in treatment is feasible and prevents weight gain in childhood acute lymphoblastic leukemia.
  Michelle Walters, Catriona Mowbray, Tracey Jubelirer, Shana Jacobs, Kara M. Kelly, Karen Smith, Yujing Yao, Zhezhen Jin, Elena J. Ladas> ;Pediatric Blood & Cancer. 2021 Feb 15
• 7 citations
  Therapeutic Targeting of Minimal Residual Disease to Prevent Late Recurrence in Hormone-Receptor Positive Breast Cancer: Challenges and New Approaches.
  David W Cescon, Kevin Kalinsky, Heather A Parsons, Karen Lisa Smith, Patricia A Spears, Alexandra Thomas, Fengmin Zhao, Angela DeMichele> ;Frontiers in Oncology. 2021 Jan 1
• 5 citations
  Low-Dose Image-Guided Pediatric CNS Radiation Therapy: Final Analysis From a Prospective Low-Dose Cone-Beam CT Protocol From a Multinational Pediatrics Consortium:
  Sara R. Alcorn, Xian Chiong Zhou, C. Bojechko, Rodrigo A. Rubo, Michael J. Chen, Karin Dieckmann, Ralph P. Ermoian, Eric C. Ford, Daria Kobyzeva, Shannon M. MacDonald,...> ;Technology in Cancer Research & Treatment. 2020 Apr 24
• 450 citations
  Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
  Elias, A., Savur Moran, M. S., William J Gradishar, Benjamin O Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H Allison, Sarah L Blair, Harold J Burstein...> ;Journal of the National Comprehensive Cancer Network. 2020 Apr 1
• 18 citations
  Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period
  Ciara C. O’Sullivan, Sheeba Irshad, Zheyu Wang, Zhuojun Tang, Christopher B. Umbricht, Gary L. Rosner, Mindy S. Christianson, Vered Stearns, Karen L. Smith> ;Breast Cancer Research and Treatment. 2020 Mar 11
• 273 citations
  Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response crit...
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Annals of Oncology. 2018 Aug 1
• 30 citations
  Physician Attitudes and Practices Related to Voluntary Error and Near-Miss Reporting
  K. Smith, K. Harris, Louis Potters, R. Sharma, Sasa Mutic, Jean L. Wright, Michael E. Samuels, Xiaobu Ye, Eric W. Ford, Stephanie A. Terezakis> ;Journal of Oncology Practice. 2014 Aug 5
• 35 citations
  BRCA mutation testing in determining breast cancer therapy
  Karen Lisa Smith, Claudine Isaacs> ;Cancer Journal. 2011 Nov 1
• 26 citations
  Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
  Claudine Isaacs, Pia Herbolsheimer, Minetta C. Liu, Mary Wilkinson, Yvonne L. Ottaviano, Gina G. Chung, Robert D. Warren, Jennifer Eng-Wong, Philip Cohen, Karen Lisa S...> ;Breast Cancer Research and Treatment. 2011 Jan 1
• 11 citations
  Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
  Chau T. Dang, Gabriella D'Andrea, Diana Lake, Steve Sugarman, Monica Fornier, Mary Ellen Moynahan, Theresa Gilewski, Arti Hurria, Nancy Mills, Tiffany A. Troso-Sandova...> ;Clinical Breast Cancer. 2008 Oct 1
• 3 citations
  Predicting breast cancer risk: implications of a "weak" family history.
  E Anderson, Jonathan Berg, Roger J Black, Nicola Bradshaw, Joyce Campbell, Roseanne Cetnarskyj, Sarah Drummond, Rosemarie Davidson, Jacqueline Dunlop, Alison Fordyce, ...> ;Familial Cancer. 2008 Jun 17
• 22 citations
  BRCA Mutations in Women with Ductal Carcinoma In situ
  Karen Lisa Smith, Muriel A. Adank, Noah D. Kauff, Kelly J. Lafaro, Jeff Boyd, Johanna B. Lee, Clifford A. Hudis, Kenneth Offit, Mark E. Robson> ;Clinical Cancer Research. 2007 Jul 15
• 12 citations
  Management of Women at Increased Risk for Hereditary Breast Cancer
  Karen Lisa Smith, Claudine Isaacs> ;Breast Disease. 2007 Jan 1
• Join now to see all